Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$14.33 - $26.0 $1.1 Million - $1.99 Million
-76,663 Reduced 14.64%
446,953 $6.32 Million
Q2 2022

Aug 15, 2022

BUY
$13.53 - $17.49 $34,866 - $45,071
2,577 Added 0.49%
523,616 $7.56 Million
Q1 2022

May 16, 2022

BUY
$15.84 - $19.64 $6.24 Million - $7.74 Million
394,073 Added 310.38%
521,039 $7.44 Million
Q4 2021

Feb 11, 2022

BUY
$17.66 - $20.42 $398,285 - $460,532
22,553 Added 21.6%
126,966 $2.4 Million
Q3 2021

Nov 15, 2021

BUY
$18.8 - $21.9 $700,506 - $816,015
37,261 Added 55.49%
104,413 $1.97 Million
Q2 2021

Aug 16, 2021

BUY
$19.89 - $22.66 $362,196 - $412,638
18,210 Added 37.21%
67,152 $1.49 Million
Q1 2021

May 13, 2021

SELL
$19.26 - $24.72 $1.44 Million - $1.85 Million
-74,967 Reduced 60.5%
48,942 $1.07 Million
Q4 2020

Feb 17, 2021

BUY
$11.16 - $20.9 $531,193 - $994,798
47,598 Added 62.37%
123,909 $2.59 Million
Q3 2020

Nov 13, 2020

SELL
$11.37 - $18.98 $220,646 - $368,325
-19,406 Reduced 20.27%
76,311 $877,000
Q2 2020

Aug 13, 2020

BUY
$12.11 - $16.12 $1.16 Million - $1.54 Million
95,717 New
95,717 $1.41 Million

About Xperi Holding Corp


  • Ticker XPER
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Application
  • Shares Outstandng 41,707,200
  • Market Cap $370M
  • Description
  • Xperi Holding Corporation, together with its subsidiaries, operates as a consumer and entertainment product/solutions licensing company worldwide. It operates through two segments, Intellectual Property Licensing and Product. The Intellectual Property Licensing segment primarily licenses its innovations to companies in the entertainment industry...
More about XPER
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.